Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENUS REMEDIES vs ASTRAZENECA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VENUS REMEDIES ASTRAZENECA PHARMA VENUS REMEDIES/
ASTRAZENECA PHARMA
 
P/E (TTM) x 15.0 95.5 15.7% View Chart
P/BV x 0.9 22.7 4.2% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 VENUS REMEDIES   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    VENUS REMEDIES
Mar-23
ASTRAZENECA PHARMA
Mar-23
VENUS REMEDIES/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs3793,620 10.5%   
Low Rs1452,438 5.9%   
Sales per share (Unadj.) Rs415.5401.2 103.6%  
Earnings per share (Unadj.) Rs19.939.7 50.0%  
Cash flow per share (Unadj.) Rs44.046.2 95.3%  
Dividends per share (Unadj.) Rs016.00 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs344.3234.4 146.9%  
Shares outstanding (eoy) m13.3725.00 53.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.67.5 8.3%   
Avg P/E ratio x13.276.3 17.3%  
P/CF ratio (eoy) x5.965.5 9.1%  
Price / Book Value ratio x0.812.9 5.9%  
Dividend payout %040.3 0.0%   
Avg Mkt Cap Rs m3,50175,718 4.6%   
No. of employees `000NANA-   
Total wages/salary Rs m5702,591 22.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5,55510,030 55.4%  
Other income Rs m103261 39.5%   
Total revenues Rs m5,65810,291 55.0%   
Gross profit Rs m6021,249 48.2%  
Depreciation Rs m323163 198.6%   
Interest Rs m36 46.7%   
Profit before tax Rs m3791,341 28.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m114348 32.6%   
Profit after tax Rs m266993 26.8%  
Gross profit margin %10.812.5 87.0%  
Effective tax rate %30.026.0 115.4%   
Net profit margin %4.89.9 48.3%  
BALANCE SHEET DATA
Current assets Rs m3,2309,359 34.5%   
Current liabilities Rs m8264,844 17.0%   
Net working cap to sales %43.345.0 96.1%  
Current ratio x3.91.9 202.4%  
Inventory Days Days3749 74.6%  
Debtors Days Days50439 1,287.3%  
Net fixed assets Rs m2,7812,061 134.9%   
Share capital Rs m13450 267.3%   
"Free" reserves Rs m4,4705,811 76.9%   
Net worth Rs m4,6035,861 78.5%   
Long term debt Rs m3870-   
Total assets Rs m6,01111,421 52.6%  
Interest coverage x130.0213.9 60.8%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.90.9 105.2%   
Return on assets %4.58.7 51.1%  
Return on equity %5.816.9 34.1%  
Return on capital %7.723.0 33.3%  
Exports to sales %00-   
Imports to sales %037.4 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA3,747 0.0%   
Fx inflow Rs m0612 0.0%   
Fx outflow Rs m03,747 0.0%   
Net fx Rs m0-3,135 -0.0%   
CASH FLOW
From Operations Rs m366583 62.8%  
From Investments Rs m-508181 -280.7%  
From Financial Activity Rs m-6-245 2.3%  
Net Cashflow Rs m-220519 -42.5%  

Share Holding

Indian Promoters % 41.8 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 1.6 5.4 29.3%  
FIIs % 1.6 2.7 59.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.2 25.0 233.0%  
Shareholders   19,560 29,032 67.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VENUS REMEDIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on VENUS REMEDIES vs ASTRAZENECA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

VENUS REMEDIES vs ASTRAZENECA PHARMA Share Price Performance

Period VENUS REMEDIES ASTRAZENECA PHARMA S&P BSE HEALTHCARE
1-Day 7.05% 0.01% 1.18%
1-Month -4.10% -3.61% -0.75%
1-Year 103.11% 59.20% 61.82%
3-Year CAGR 4.62% 20.50% 18.16%
5-Year CAGR 58.05% 22.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the VENUS REMEDIES share price and the ASTRAZENECA PHARMA share price.

Moving on to shareholding structures...

The promoters of VENUS REMEDIES hold a 41.8% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VENUS REMEDIES and the shareholding pattern of ASTRAZENECA PHARMA.

Finally, a word on dividends...

In the most recent financial year, VENUS REMEDIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

ASTRAZENECA PHARMA paid Rs 16.0, and its dividend payout ratio stood at 40.3%.

You may visit here to review the dividend history of VENUS REMEDIES, and the dividend history of ASTRAZENECA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.